Location History:
- Rensselner, NY (US) (2013)
- Rensselaer, NY (US) (2015 - 2017)
Company Filing History:
Years Active: 2013-2017
Title: Nainesh Shah: Innovator in Pharmaceutical Chemistry
Introduction
Nainesh Shah is a distinguished inventor based in Rensselaer, NY, renowned for his contributions to pharmaceutical chemistry. With a total of three patents under his name, Shah has made significant strides in the development of compounds that impact serotonin receptor activity, which are crucial for various therapeutic applications.
Latest Patents
Nainesh Shah's latest patents focus on processes for preparing phenyl-pyrazoles of Formula (I), along with their salts and pharmaceutical compositions. These compounds are recognized for their role as modulators of 5-HT serotonin receptor activity. His inventions also encompass the intermediates used in these processes and the methods for their preparation. Furthermore, Shah's work includes the development of crystalline forms of serotonin receptor modulators and compositions, which expands the therapeutic possibilities of these important chemical compounds.
Career Highlights
Shah is currently employed at Arena Pharmaceuticals, Inc., where he is engaged in cutting-edge research and development. His expertise in pharmaceutical composition and receptor modulation aligns with the company's mission to innovate advanced therapies for unmet medical needs.
Collaborations
Throughout his career, Nainesh Shah has collaborated with notable colleagues such as Tawfik Gharbaoui and Dipanjan Sengupta. These partnerships highlight the collaborative nature of innovation in the pharmaceutical field, bringing together diverse expertise to enhance the development of impactful therapies.
Conclusion
Nainesh Shah is a pivotal figure in the field of pharmaceutical innovation, with a focus on serotonin receptor modulators. His patents and collaborative efforts underscore the importance of research in advancing medical therapies, making significant contributions to the science of drug development. With a promising career at Arena Pharmaceuticals, he continues to drive forward the boundaries of pharmaceutical chemistry.